Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CTLA4 anticorps

L’anticorps anti-CTLA4 Monoclonal Souris est utilisé pour la détection de CTLA4 dans des échantillons de Souris, Rat, Boeuf (Vache) et Cat. Il a été validé pour WB, FACS et IF.
N° du produit ABIN6937038
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour CTLA4 anticorps (ABIN6937038)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Reactivité

  • 195
  • 118
  • 54
  • 14
  • 10
  • 1
Souris, Rat, Boeuf (Vache), Cat

Hôte

  • 108
  • 106
  • 23
  • 22
  • 10
  • 3
  • 2
  • 1
  • 1
Souris

Clonalité

  • 203
  • 70
  • 3
Monoclonal

Conjugué

  • 138
  • 22
  • 21
  • 20
  • 15
  • 7
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 104
  • 86
  • 67
  • 52
  • 35
  • 29
  • 28
  • 16
  • 13
  • 10
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

L4P2F5-F10
  • Fonction

    CTLA4 / CD152 (Negative Regulator of T-Cells) Antibody

    Specificité

    CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 Molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule.

    Réactivité croisée (Details)

    Cow, Cat, Mouse and Rat. Does not react with Human.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    A synthetic peptide from CTLA4 (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), ,Immunofluorescence (1-2 μg/mL), ,Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat or Raji cells. Lymph node or tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA4

    Sujet

    ALPS5, CD152, Celiac disease 3 (CELIAC3), Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), GRD4, GSE, ICOS, Insulin-dependent Diabetes Mellitus 12 (IDDM12)

    Jurkat or Raji cells. Lymph node or tonsil.

    Poids moléculaire

    30-43kDa

    ID gène

    1493, 247824

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!